ZA200904755B - Use of epothilones in the treatment of osteoporosis and related diseases - Google Patents

Use of epothilones in the treatment of osteoporosis and related diseases

Info

Publication number
ZA200904755B
ZA200904755B ZA200904755A ZA200904755A ZA200904755B ZA 200904755 B ZA200904755 B ZA 200904755B ZA 200904755 A ZA200904755 A ZA 200904755A ZA 200904755 A ZA200904755 A ZA 200904755A ZA 200904755 B ZA200904755 B ZA 200904755B
Authority
ZA
South Africa
Prior art keywords
epothilones
osteoporosis
treatment
related diseases
diseases
Prior art date
Application number
ZA200904755A
Other languages
English (en)
Inventor
Jens Hoffmann
Sanna Kaekoenen
Ulrich Klar
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38008136&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200904755(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of ZA200904755B publication Critical patent/ZA200904755B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA200904755A 2006-12-08 2009-07-07 Use of epothilones in the treatment of osteoporosis and related diseases ZA200904755B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06025424A EP1930004A1 (en) 2006-12-08 2006-12-08 Use of epothilones in the treatment of osteoporosis and related diseases

Publications (1)

Publication Number Publication Date
ZA200904755B true ZA200904755B (en) 2010-09-29

Family

ID=38008136

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200904755A ZA200904755B (en) 2006-12-08 2009-07-07 Use of epothilones in the treatment of osteoporosis and related diseases

Country Status (15)

Country Link
US (1) US20080146626A1 (pt)
EP (2) EP1930004A1 (pt)
KR (1) KR20090087038A (pt)
CN (1) CN101553227A (pt)
AR (1) AR064214A1 (pt)
AU (1) AU2007327767A1 (pt)
BR (1) BRPI0719997A2 (pt)
CA (1) CA2672114A1 (pt)
CL (1) CL2007003553A1 (pt)
IL (1) IL198493A0 (pt)
MX (1) MX2009006074A (pt)
TW (1) TW200829239A (pt)
UY (1) UY30769A1 (pt)
WO (1) WO2008068043A1 (pt)
ZA (1) ZA200904755B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103037903A (zh) 2010-05-18 2013-04-10 天蓝制药公司 用于治疗自身免疫性疾病或其它疾病的组合物和方法
RU2496511C1 (ru) * 2012-04-20 2013-10-27 Замертон Холдингс Лимитед Фармацевтическая композиция, средство (варианты) и способ профилактики и лечения артрита, остеоартроза и остеохондроза позвоночника (варианты)
WO2017066606A1 (en) * 2015-10-16 2017-04-20 William Marsh Rice University Epothilone analogs, methods of synthesis, methods of treatment, and drug conjugates thereof
CN110974824A (zh) * 2019-12-18 2020-04-10 中国人民解放军陆军军医大学第一附属医院 埃博霉素b在制备防治炎症性骨丢失药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6320045B1 (en) * 1997-12-04 2001-11-20 Bristol-Myers Squibb Company Process for the reduction of oxiranyl epothilones to olefinic epothilones
US6893859B2 (en) * 2001-02-13 2005-05-17 Kosan Biosciences, Inc. Epothilone derivatives and methods for making and using the same
AU2002338336A1 (en) * 2001-04-03 2002-10-21 Kosan Biosciences, Inc. Epothilone derivatives and methods for making and using the same
EP1640004A1 (en) * 2004-09-24 2006-03-29 Schering Aktiengesellschaft Use of epothilones in the treatment of bone metastases and bone tumors or cancers
US20060069136A1 (en) * 2004-09-24 2006-03-30 Ulrich Klar Use of Epothilones in the treatment of bone metastasis

Also Published As

Publication number Publication date
AU2007327767A1 (en) 2008-06-12
TW200829239A (en) 2008-07-16
UY30769A1 (es) 2008-07-31
CA2672114A1 (en) 2008-06-12
IL198493A0 (en) 2010-02-17
CL2007003553A1 (es) 2008-07-04
KR20090087038A (ko) 2009-08-14
BRPI0719997A2 (pt) 2014-03-18
AR064214A1 (es) 2009-03-18
MX2009006074A (es) 2009-08-24
CN101553227A (zh) 2009-10-07
EP2101765A1 (en) 2009-09-23
US20080146626A1 (en) 2008-06-19
WO2008068043A1 (en) 2008-06-12
EP1930004A1 (en) 2008-06-11

Similar Documents

Publication Publication Date Title
GB2439393B (en) Cannabinoids for use in the treatment of neuropathic pain
GB0625659D0 (en) Therapeutic compounds and their use
IL199045A0 (en) Antagonist anti-notch3 antibodies and their use in the prevention and treatment of notch3-related diseases
PL1978947T3 (pl) Nitrooksypochodne do zastosowania w leczeniu dystrofii mięśniowych
EP2007385A4 (en) CARDIOVASCULAR COMPOSITION AND ITS USE FOR THE TREATMENT OF MORBUS ALZHEIMER
PT2101731T (pt) Endoxifeno para utilização no tratamento de cancro
ZA200902419B (en) Anti-notch3 agonist antibodies and their use in the treatment of notch3-related diseases
PL1912650T3 (pl) Zastosowanie flibanseryny w leczeniu otyłości
ZA200806808B (en) Treatment of stressed patients
PL1685834T3 (pl) Zastosowanie kwasu pinolenowego do leczenia otyłości
EP2012798A4 (en) USE OF INOSITOL-TRIPYROPHOSPHATE IN THE TREATMENT OF TUMORS AND DISEASES
PL2148667T3 (pl) Stosowanie pochodnych cycloheksanoheksolu w leczeniu chorób oczu
PL2012805T3 (pl) Kompozycja lecznicza i jej zastosowanie
ZA201001207B (en) Therapeutic formulations for the treatment of cold and flu-like symptoms
ZA201108106B (en) Use of phthalimide derivatives in the treatment of diseases
IL198493A0 (en) Use of epothilones in the treatment of osteoporosis and related diseases
EP1954800A4 (en) COMPOSITION AND USE OF PHYTO-PERCOLATE FOR THE TREATMENT OF DISEASE
EP1928247A4 (en) COMPOSITION AND USE OF PHYTO-PERCOLATE FOR THE TREATMENT OF DISEASE
GB0619816D0 (en) Novel interferon-alpha constructs for use in the treatment of cancer
SI2182954T1 (sl) Uporaba nor-žolčnih kislin pri zdravljenju arterioskleroze
IL185575A0 (en) Benzoxazocines and their therapeutic use
GB0620695D0 (en) Composition and methods for the treatment of nurdegenerative disease
ZA200904382B (en) Antagonist anti-Notch3 antibodies and their use in the prevention and treatment of Notch3-retaled diseases
IL181785A0 (en) Use of epothilones in the treatment of bone metastasis
GB0614538D0 (en) Therapeutic Compounds And Their Use